IDH1 and myelodysplastic syndrome: This occurs in several types of myeloid malignancies, like MDS [58], where IDH1/2 mutations induce the conversion of aKG into the oncometabolite 2‐HG and therefore, as mentioned earlier, the impairment of proper aKG‐dependent DNA demethylase TET protein function.